The mass-market edition of To Kill a Mockingbird will no longer be available in the U.S.
Just days after Harper Lee's will was sealed from public view, Hachette Book Group sent out an email to booksellers across the country announcing that Lee's estate would no longer allow mass-market editions of the classic To Kill a Mockingbird to be published.
The kill on the mass-market paperbacks, which are smaller in size and notably cheaper than trade paperbacks, will force readers to pay as much as nearly double the price for the classic novel, as Hachette's mass-market paperback sells for $8.99 while trade paperbacks sell for between $14.99 and $16.99. Due to the price difference, mass-market paperbacks are typically sold at significantly higher volumes than trade paperbacks. Since January 2016, 55,376 copies of HarperCollins' mass-market editions of To Kill a Mockingbird have sold, as compared to only 22,554 copies of the trade paperback editions.
The announcement is a particular blow to schools, which rely heavily on mass-market paperbacks. Lee's classic is currently taught in 74 percent of U.S. schools, but The New Republic notes that if schools aren't able to fork over the cash for the trade paperback editions, that percentage could soon decline.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
No explanation has been provided from Lee's estate. While mass-market paperbacks have generally been declining in popularity in the publishing world, To Kill a Mockingbird has been an exception. The New Republic reports that the estate will likely receive more money in royalties because of the switch.
Read the full story over at The New Republic.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
The week's best photos
In Pictures A cyclone's aftermath, a fearless leap, and more
By Anahi Valenzuela, The Week US Published
-
The Imaginary Institution of India: a 'compelling' exhibition
The Week Recommends 'Vibrant' show at the Barbican examines how political upheaval stimulated Indian art
By The Week UK Published
-
Nobody seems surprised Wagner's Prigozhin died under suspicious circumstances
Speed Read
By Peter Weber Published
-
Western mountain climbers allegedly left Pakistani porter to die on K2
Speed Read
By Justin Klawans Published
-
'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governor
Speed Read
By Peter Weber Published
-
Los Angeles city workers stage 1-day walkout over labor conditions
Speed Read
By Justin Klawans Published
-
Mega Millions jackpot climbs to an estimated $1.55 billion
Speed Read
By Catherine Garcia Published
-
Bangladesh dealing with worst dengue fever outbreak on record
Speed Read
By Catherine Garcia Published
-
Glacial outburst flooding in Juneau destroys homes
Speed Read
By Catherine Garcia Published
-
Scotland seeking 'monster hunters' to search for fabled Loch Ness creature
Speed Read
By Justin Klawans Published